Skip to main content

iRadimed Corporation (IRMD) Stock Analysis

Buy WaitModerate Confidence

Healthcare · Medical Devices

Earnings in 1 day (2026-05-01). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait — supporting gate not met yet. Price is at or below entry $87.84 but weak momentum still blocks BUY_NOW.

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI... Read more

$82.30+27.4% A.UpsideScore 5.3/10#27 of 40 Medical Devices
Entry $87.84(Atr Pullback Sticky)Stop $81.59Target $100.87(analyst − 15%)A.R:R 3.0:1
Analyst target$118.67+44.2%3 analysts
$100.87our TP
$82.30price
$118.67mean
$120

Wait — supporting gate not met yet. Price is at or below entry $87.84 but weak momentum still blocks BUY_NOW. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 1 day. Wait until post-earnings. Score 5.3/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and earnings proximity 1d<=7d. Suitability: aggressive.

Val3.7Qual7.4Grw6.9Mom1.2Sent6.4Ins3.0Peer5.5Tech8.3Risk3.85.3OVERALL

Thesis

Rewards
No bull case signals
Risks
No bear case signals

Key Metrics

P/E (TTM)47.8
P/E (Fwd)36.1
Mkt Cap$1.1B
EV/EBITDA37.3
Profit Mgn26.8%
ROE24.8%
Rev Growth17.0%
Beta1.12
Dividend0.96%
Rating analysts8

Quality Signals

Piotroski F9/9

Options Flow

P/C6.50bearish
IV66%elevated
Max Pain$55-33.2% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
3.0
Capitulation risk (RSI 19, below 200MA)Volume distribution (falling OBV)Below 200-MA but MA still rising (+6.5%/30d) — pullback in uptrend, not confirmed weakness

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Ps
1.5
Pe
2.6
Forward Pe
3.0
Peg Ratio
5.2
Analyst Target
7.5
Forward P/E: 36.1xPEG: 1.45
GatesMomentum 1.2<4.5EARNINGS PROXIMITY 1d<=7dA.R:R 3.0 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
19 · Oversold
↓ 20D MA↓ 50D MA↓ 200D MAGOLDEN CROSSSupport $81.68Resistance $98.18

Price Targets

$82
$88
$101
A.Upside+22.6%
A.R:R3.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Earnings in 1 day - binary event risk
! Momentum score 1.2/10 — below 4.5 minimum
! EARNINGS_PROXIMITY:1d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-05-01 (1d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is IRMD stock a buy right now?

Wait — supporting gate not met yet. Price is at or below entry $87.84 but weak momentum still blocks BUY_NOW. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 1 day. Wait until post-earnings. Target $100.87 (+22.6%), stop $81.59 (−0.9%), Setup A.R:R 3.9:1. Score 5.3/10, moderate confidence.

What is the IRMD stock price target?

Take-profit target: $100.87 (+27.4% upside). Target $100.87 (+22.6%), stop $81.59 (−0.9%), Setup A.R:R 3.9:1. Stop-loss: $81.59.

Is IRMD overvalued or undervalued?

iRadimed Corporation trades at a P/E of 47.8 (forward 36.1). TrendMatrix value score: 3.7/10. Verdict: Buy (Wait for Entry).

What do analysts say about IRMD?

8 analysts cover IRMD with a consensus score of 4.1/5. Average price target: $119.

What does iRadimed Corporation do?IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible...

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Related stocks: TMDX (TransMedics Group, Inc.) · ATEC (Alphatec Holdings, Inc.) · HAE (Haemonetics Corporation) · INSP (Inspire Medical Systems, Inc.) · IRTC (iRhythm Holdings, Inc.)